Synthesis and characterization of silver nanoparticles loaded with carboplatin as a potential antimicrobial and cancer therapy

In recent studies with silver nanoparticles, it has been reported that the use of nanoparticles in carrier drug systems increases tumor suppression and reduces drug-related side effects. At the same time, the combination of traditional medicine with nanotechnology provides the opportunity to develop...

Full description

Saved in:
Bibliographic Details
Published inCancer nanotechnology Vol. 15; no. 1; pp. 2 - 14
Main Author Tunç, Tutku
Format Journal Article
LanguageEnglish
Published Vienna Springer Vienna 01.12.2024
Springer Nature B.V
BMC
Subjects
Online AccessGet full text
ISSN1868-6958
1868-6966
1868-6966
DOI10.1186/s12645-023-00243-1

Cover

Abstract In recent studies with silver nanoparticles, it has been reported that the use of nanoparticles in carrier drug systems increases tumor suppression and reduces drug-related side effects. At the same time, the combination of traditional medicine with nanotechnology provides the opportunity to develop new antimicrobial agents. The aim of this study was to determine the anticancer, antimicrobial activities and pro-apoptotic effects of silver nanoparticles (AgNPs), and carboplatin-loaded silver nanoparticles (AgNPs-Car). Characterization studies of the synthesized nanoparticles were carried out by DLS, EDX-STEM, and FTIR analysis. The antiproliferative and pro-apoptotic effects of these molecules were evaluated using XTT and Annexin V, respectively. MIC (Minimum Inhibitory Concentration) test was used to determine the antimicrobial activity. The anticancer activity of the AgNPs-Car was high in MCF-7 (human breast adenocarcinoma), A549 (human lung carcinoma), and C6 (brain glioma) cells. The cell group with the most effective selective cytotoxic activity was C6 cells. It was also shown that AgNPs-Car and AgNPs induced DNA fragmentation eventually increasing apoptosis of cells. The antimicrobial activity of AgNPs and AgNPs-Car was evaluated on Gram-positive and Gram-negative pathogenic microorganisms and yeast fungi. Among the nanomaterials that reached effective MIC values according to reference sources, AgNPs-Car achieved better results. As a result, AgNPs-Car was found to be very successful in targeting C6 glioma cells by facilitating cell entry of the drug. In addition, their anticancer activity on MCF-7 and A549 cells was high and their toxicity was low. Silver nanoparticles are preferred for creating a better drug carrier system because of their qualitative properties and effects. Therefore, it is an interesting field for research on targeting cancer cells and pathogenic microorganisms.
AbstractList Abstract In recent studies with silver nanoparticles, it has been reported that the use of nanoparticles in carrier drug systems increases tumor suppression and reduces drug-related side effects. At the same time, the combination of traditional medicine with nanotechnology provides the opportunity to develop new antimicrobial agents. The aim of this study was to determine the anticancer, antimicrobial activities and pro-apoptotic effects of silver nanoparticles (AgNPs), and carboplatin-loaded silver nanoparticles (AgNPs-Car). Characterization studies of the synthesized nanoparticles were carried out by DLS, EDX-STEM, and FTIR analysis. The antiproliferative and pro-apoptotic effects of these molecules were evaluated using XTT and Annexin V, respectively. MIC (Minimum Inhibitory Concentration) test was used to determine the antimicrobial activity. The anticancer activity of the AgNPs-Car was high in MCF-7 (human breast adenocarcinoma), A549 (human lung carcinoma), and C6 (brain glioma) cells. The cell group with the most effective selective cytotoxic activity was C6 cells. It was also shown that AgNPs-Car and AgNPs induced DNA fragmentation eventually increasing apoptosis of cells. The antimicrobial activity of AgNPs and AgNPs-Car was evaluated on Gram-positive and Gram-negative pathogenic microorganisms and yeast fungi. Among the nanomaterials that reached effective MIC values according to reference sources, AgNPs-Car achieved better results. As a result, AgNPs-Car was found to be very successful in targeting C6 glioma cells by facilitating cell entry of the drug. In addition, their anticancer activity on MCF-7 and A549 cells was high and their toxicity was low. Silver nanoparticles are preferred for creating a better drug carrier system because of their qualitative properties and effects. Therefore, it is an interesting field for research on targeting cancer cells and pathogenic microorganisms.
In recent studies with silver nanoparticles, it has been reported that the use of nanoparticles in carrier drug systems increases tumor suppression and reduces drug-related side effects. At the same time, the combination of traditional medicine with nanotechnology provides the opportunity to develop new antimicrobial agents. The aim of this study was to determine the anticancer, antimicrobial activities and pro-apoptotic effects of silver nanoparticles (AgNPs), and carboplatin-loaded silver nanoparticles (AgNPs-Car). Characterization studies of the synthesized nanoparticles were carried out by DLS, EDX-STEM, and FTIR analysis. The antiproliferative and pro-apoptotic effects of these molecules were evaluated using XTT and Annexin V, respectively. MIC (Minimum Inhibitory Concentration) test was used to determine the antimicrobial activity. The anticancer activity of the AgNPs-Car was high in MCF-7 (human breast adenocarcinoma), A549 (human lung carcinoma), and C6 (brain glioma) cells. The cell group with the most effective selective cytotoxic activity was C6 cells. It was also shown that AgNPs-Car and AgNPs induced DNA fragmentation eventually increasing apoptosis of cells. The antimicrobial activity of AgNPs and AgNPs-Car was evaluated on Gram-positive and Gram-negative pathogenic microorganisms and yeast fungi. Among the nanomaterials that reached effective MIC values according to reference sources, AgNPs-Car achieved better results. As a result, AgNPs-Car was found to be very successful in targeting C6 glioma cells by facilitating cell entry of the drug. In addition, their anticancer activity on MCF-7 and A549 cells was high and their toxicity was low. Silver nanoparticles are preferred for creating a better drug carrier system because of their qualitative properties and effects. Therefore, it is an interesting field for research on targeting cancer cells and pathogenic microorganisms.
ArticleNumber 2
Author Tunç, Tutku
Author_xml – sequence: 1
  givenname: Tutku
  orcidid: 0000-0002-8274-9386
  surname: Tunç
  fullname: Tunç, Tutku
  email: tutkutunc58@hotmail.com
  organization: Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Sivas Cumhuriyet University
BookMark eNqNkcluFDEQhi0UJELIC3CyxLnBS4_bPqKIJVIkDsDZKrurMx517Mb2EA2HPDtmehQkDhG-eKv_q-V_Sc5iikjIa87ecq7Vu8KF6jcdE7JjTPSy48_IefvQnTJKnT2eN_oFuSxlx9qSxhhmzsnD10OsWyyhUIgj9VvI4Cvm8AtqSJGmiZYw_8RMI8S0QK7Bz1jonGDEkd6HuqUeskvL3ASRQuPQJVWMNcDcmDXcBZ-TW28tA0TfaC1nhuXwijyfYC54edovyPePH75dfe5uvny6vnp_0_lemNoh20yD4SBHcJIpLsVGgFNMDUyiYj0ogTgMkhlvBnTovODYQ--lmLRxSl6Q65U7JtjZJYc7yAebINjjQ8q39tSadW2Wo2JCMa17NSnXj5PSqECIaXDj0FhyZe3jAod7mOdHIGf2jyN2dcQ2R-zREcub6s2qWnL6scdS7S7tc2xNW2E4G4Ruihal16g2slIyTtaHenSiZgjz0wnEP9L_qurUS2nB8Rbz36qeUP0G46y_5A
CitedBy_id crossref_primary_10_1002_slct_202403760
crossref_primary_10_3389_fchem_2024_1508707
crossref_primary_10_3389_fphar_2024_1438227
crossref_primary_10_1007_s12668_024_01443_8
crossref_primary_10_1016_j_nanoso_2024_101363
crossref_primary_10_1002_adhm_202403059
crossref_primary_10_1021_acsomega_4c10445
crossref_primary_10_3390_pharmaceutics16091181
crossref_primary_10_1186_s12645_024_00255_5
crossref_primary_10_1007_s10895_025_04146_9
crossref_primary_10_1016_j_inoche_2024_112979
crossref_primary_10_1016_j_talanta_2024_126790
crossref_primary_10_3390_ijms252312494
crossref_primary_10_1016_j_mtcomm_2025_111876
crossref_primary_10_1155_2024_9916187
crossref_primary_10_1080_00222348_2024_2380941
crossref_primary_10_1016_j_matchemphys_2025_130534
Cites_doi 10.1016/j.drup.2009.09.001
10.1166/jbn.2012.1451
10.1155/2014/150845
10.1016/j.inoche.2022.110380
10.1055/s-0030-1250027
10.1016/j.crgsc.2021.100205
10.7150/thno.45413
10.1016/j.ijbiomac.2016.12.090
10.1038/nrd2614
10.1038/s41598-018-32480-5
10.1021/bm501285t
10.3389/fmicb.2018.01555
10.3390/su10040913
10.4038/sljid.v8i1.8167
10.1080/16878507.2020.1748941
10.2147/IJN.S191340
10.1007/s13277-014-1630-9
10.1016/j.tiv.2019.104600
10.3390/microorganisms8091400
10.1016/j.jdent.2017.12.003
10.3390/nano11081999
10.1373/clinchem.2015.241190
10.1039/C8RA08982E
10.1016/j.ijpharm.2020.119283
10.1155/2022/2663812
10.30616/ajb.391985
10.1038/s41598-022-20360-y
10.3390/ph14060509
10.1016/j.matpr.2022.04.199
10.1016/j.colsurfb.2021.112254
10.1016/j.jddst.2020.102265
10.1007/s10904-021-01973-8
10.1016/j.mtcomm.2019.100884
10.1126/scitranslmed.3006276
10.1016/j.jviromet.2016.12.015
10.3390/molecules26113067
10.1016/j.colsurfb.2018.12.043
10.1007/s42452-019-1353-z
10.3390/pharmaceutics12090821
10.3390/pharmaceutics13071000
10.2147/IJN.S11727
10.1007/s12011-019-01791-7
10.3390/nano11040964
10.1016/j.jddst.2020.102039
10.1002/anie.201207721
10.1038/nrmicro3028
10.1186/1749-8546-6-39
10.1186/1472-6882-13-289
10.1021/acs.jmedchem.0c01055
10.1259/bjr/83796755
10.3390/pharmaceutics14102183
10.22034/JCHR.2021.1937062.1373
10.1088/1757-899X/757/1/012028
10.1155/2020/1215395
10.1088/1757-899X/454/1/012077
10.1088/1742-6596/1003/1/012100
10.3390/pharmaceutics14102185
ContentType Journal Article
Copyright The Author(s) 2024
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
8AO
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
AZQEC
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
HCIFZ
K9.
L6V
M0S
M7S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
ADTOC
UNPAY
DOA
DOI 10.1186/s12645-023-00243-1
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Technology Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
SciTech Premium Collection (Proquest)
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
Health & Medical Collection (Alumni Edition)
Engineering Database (Proquest)
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
Engineering Collection
Engineering Database
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList

CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Openly Available Collection - DOAJ
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1868-6966
EndPage 14
ExternalDocumentID oai_doaj_org_article_b645d602608846f6b4df68e6a22f7bd7
10.1186/s12645-023-00243-1
10_1186_s12645_023_00243_1
GroupedDBID ---
-58
-5G
-A0
-BR
0R~
0VY
1N0
2JY
2VQ
30V
3V.
4.4
408
409
40D
7X7
875
8AO
8FE
8FG
8FI
8FJ
8TC
AAFWJ
AAJSJ
AAKKN
AAYZH
ABEEZ
ABJCF
ABUWG
ACACY
ACGFS
ACIWK
ACULB
ADBBV
ADINQ
ADUKV
AFGXO
AFKRA
AFWTZ
AGJBK
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
BAPOH
BCNDV
BENPR
BFQNJ
BGLVJ
BGNMA
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
EBLON
EBS
EJD
F5P
FYUFA
GQ6
GQ8
GROUPED_DOAJ
HCIFZ
HF~
HMCUK
HMJXF
HZ~
IZIGR
KOV
L6V
M4Y
M7S
M~E
NU0
O9-
O93
OK1
P9N
PIMPY
PQQKQ
PROAC
PTHSS
QOS
R9I
RSV
S1Z
S27
S3B
SCM
SOJ
T13
TSV
TUS
U2A
UKHRP
WK8
Z45
Z85
~A9
AASML
AAYXX
AFPKN
CITATION
PUEGO
7XB
8FK
AZQEC
DWQXO
K9.
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
ABFSG
ACSTC
ADTOC
AEZWR
AFHIU
AHWEU
AIXLP
UNPAY
ID FETCH-LOGICAL-c429t-e05f791a3dab30613252ab606703e604a62ee77309c97ebebc21e4a4c32f89b63
IEDL.DBID BENPR
ISSN 1868-6958
1868-6966
IngestDate Fri Oct 03 12:41:58 EDT 2025
Wed Oct 01 15:32:39 EDT 2025
Sat Oct 11 13:40:35 EDT 2025
Wed Oct 01 03:23:10 EDT 2025
Thu Apr 24 23:04:25 EDT 2025
Fri Feb 21 02:40:41 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Antimicrobial
AgNPs
Carboplatin
Drug carrier
Apoptosis
Language English
License cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c429t-e05f791a3dab30613252ab606703e604a62ee77309c97ebebc21e4a4c32f89b63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0002-8274-9386
OpenAccessLink https://www.proquest.com/docview/2910728645?pq-origsite=%requestingapplication%&accountid=15518
PQID 2910728645
PQPubID 2034790
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_b645d602608846f6b4df68e6a22f7bd7
unpaywall_primary_10_1186_s12645_023_00243_1
proquest_journals_2910728645
crossref_citationtrail_10_1186_s12645_023_00243_1
crossref_primary_10_1186_s12645_023_00243_1
springer_journals_10_1186_s12645_023_00243_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-01
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Vienna
PublicationPlace_xml – name: Vienna
– name: Heidelberg
PublicationSubtitle Basic,Translational and Clinical Research
PublicationTitle Cancer nanotechnology
PublicationTitleAbbrev Cancer Nano
PublicationYear 2024
Publisher Springer Vienna
Springer Nature B.V
BMC
Publisher_xml – name: Springer Vienna
– name: Springer Nature B.V
– name: BMC
References Khan, Zafaryab, Mehdi (CR29) 2017; 97
Mohsen, El-Borady, Mohamed, Fahim (CR45) 2020; 13
Bahjat, Ismail, Sulaiman, Jabir (CR4) 2021; 31
Iliescu, Andronescu, Ghitulica (CR23) 2011; 73
Krishnan, Banas, Durai (CR33) 2020; 12
Ghaferi, Raza, Koohi (CR13) 2022; 14
Kaur, Preet, Kumar (CR28) 2019; 176
Roy, Bulut, Some, Mandal, Yilmaz (CR51) 2019; 9
Lee, Chen, Noh (CR35) 2013; 52
Vishwanath, Negi (CR59) 2021; 4
Ebrahimi Shahmabadi, Movahedi, Koohi Moftakhari Esfahani (CR11) 2014; 35
Morones-Ramirez, Winkler, Spina, Collins (CR47) 2013; 5
CR31
CR30
Davis, Chen, Shin (CR10) 2008; 7
Lemire, Harrison, Turner (CR36) 2013; 11
Mahmood, Kadhim, Ibraheem, Albukhaty (CR40) 2022; 12
Gomes, Martins, Prior (CR15) 2021; 11
Morais, Teixeira, Dias (CR46) 2020; 63
Hassanzadeganroudsari, Soltani, Heydarinasab (CR17) 2020; 60
Sehgal, Kumar (CR52) 2022
CR6
Hassan, Watari, AbuAlmaaty, Ohba, Sakuragi (CR16) 2014
CR7
Koca, Köken, Özkurt, Gökhan, Kabadere, Erkasap, Oğuzhan, Çolak (CR32) 2022; 2
Sezari, Shamaei (CR53) 2021; 11
CR44
Miranda, Sampaio, Zucolotto (CR42) 2022; 210
Rock, McArdle, Forde (CR50) 2012; 85
Bharadwaj, Rabha, Pati, Choudhury, Sarkar, Gogoi (CR5) 2021; 11
Awouafack, McGaw, Gottfried (CR3) 2013; 13
Cruz-Ramírez, Valenzuela-Salas, Blanco-Salazar (CR8) 2021; 13
Aparicio-Blanco, Sanz-Arriazu, Lorenzoni, Blanco-Prieto (CR2) 2020; 581
Jihad, Noori, Jabir (CR26) 2021; 26
Plackal, Kumar, Abrahamse, Ray (CR49) 2018; 8
Danışman-Kalındemirtaş, Kariper, Hepokur (CR9) 2021; 61
Yaseen, Gangwar, Nayak (CR61) 2022; 149
CR58
Jabir, Rashid, Nayef (CR25) 2022
Shahzad, Lopez-Berestein, Sood (CR54) 2009; 12
Machana, Weerapreeyakul, Barusrux (CR39) 2011; 6
He, Lin, Kong, Huang, Xu (CR18) 2015; 61
Al-Nuairi, Mosa, Mohammad (CR1) 2020; 194
Hepokur, Kariper, Mısır (CR20) 2019; 61
Giakoumettis, Kritis, Foroglou (CR14) 2018; 22
Shaik, Khan, Kuniyil (CR55) 2018; 10
Sriram, Kanth, Kalishwaralal, Gurunathan (CR56) 2010; 5
Karuppaiah, Siram, Selvaraj (CR27) 2020; 23
Ibrahim, Kareem, Al-Noor, Al-Muhimeed, AlObaid, Albukhaty, Sulaiman, Jabir, Taqi, Sahib (CR22) 2021; 14
Huy, Thanh, Thuy (CR21) 2017; 241
Mofidian, Barati, Jahanshahi, Shahavi (CR43) 2019; 1
Loo, Rukayadi, Nor-Khaizura (CR38) 2018; 9
Paiva, Fidalgo, Da Costa (CR48) 2018; 69
Talapko, Matijević, Juzbašić (CR57) 2020; 8
CR24
Kuete (CR34) 2010; 76
Hekmat, Saboury, Divsalar (CR19) 2012; 8
Fernando, Gunasekara, Holton (CR12) 2018; 8
Liao, Zhang, Pan, Zhu (CR37) 2019; 14
Mignani, Bryszewska, Klajnert-Maculewicz (CR41) 2015; 16
Xu, Yi-Yi, Huang, Chun-Yuan (CR60) 2020; 10
RR Miranda (243_CR42) 2022; 210
243_CR58
Y He (243_CR18) 2015; 61
V Kuete (243_CR34) 2010; 76
RI Iliescu (243_CR23) 2011; 73
MA Jihad (243_CR26) 2021; 26
M Hassanzadeganroudsari (243_CR17) 2020; 60
HI Gomes (243_CR15) 2021; 11
J Talapko (243_CR57) 2020; 8
ME Davis (243_CR10) 2008; 7
243_CR24
K Rock (243_CR50) 2012; 85
F Danışman-Kalındemirtaş (243_CR9) 2021; 61
MA Khan (243_CR29) 2017; 97
A Karuppaiah (243_CR27) 2020; 23
R Mofidian (243_CR43) 2019; 1
HR Sezari (243_CR53) 2021; 11
D Giakoumettis (243_CR14) 2018; 22
AA Ibrahim (243_CR22) 2021; 14
MM Shahzad (243_CR54) 2009; 12
KK Bharadwaj (243_CR5) 2021; 11
243_CR7
HB Koca (243_CR32) 2022; 2
JA Lemire (243_CR36) 2013; 11
S Machana (243_CR39) 2011; 6
JR Morones-Ramirez (243_CR47) 2013; 5
243_CR6
M Morais (243_CR46) 2020; 63
B Yaseen (243_CR61) 2022; 149
M Ghaferi (243_CR13) 2022; 14
S Mignani (243_CR41) 2015; 16
JH Lee (243_CR35) 2013; 52
R Vishwanath (243_CR59) 2021; 4
L Paiva (243_CR48) 2018; 69
E Mohsen (243_CR45) 2020; 13
HH Bahjat (243_CR4) 2021; 31
AGB Plackal (243_CR49) 2018; 8
OU Cruz-Ramírez (243_CR8) 2021; 13
RI Mahmood (243_CR40) 2022; 12
A Hekmat (243_CR19) 2012; 8
C Hepokur (243_CR20) 2019; 61
243_CR44
PD Krishnan (243_CR33) 2020; 12
L Xu (243_CR60) 2020; 10
A Kaur (243_CR28) 2019; 176
MD Awouafack (243_CR3) 2013; 13
MR Shaik (243_CR55) 2018; 10
MI Sriram (243_CR56) 2010; 5
S Sehgal (243_CR52) 2022
MS Jabir (243_CR25) 2022
M Hassan (243_CR16) 2014
TQ Huy (243_CR21) 2017; 241
J Aparicio-Blanco (243_CR2) 2020; 581
A Roy (243_CR51) 2019; 9
H Ebrahimi Shahmabadi (243_CR11) 2014; 35
S Liao (243_CR37) 2019; 14
243_CR30
AG Al-Nuairi (243_CR1) 2020; 194
243_CR31
YY Loo (243_CR38) 2018; 9
SSN Fernando (243_CR12) 2018; 8
References_xml – volume: 12
  start-page: 148
  issue: 6
  year: 2009
  end-page: 152
  ident: CR54
  article-title: Novel strategies for reversing platinum resistance
  publication-title: Drug Resist Updat
  doi: 10.1016/j.drup.2009.09.001
– volume: 8
  start-page: 968
  issue: 6
  year: 2012
  end-page: 982
  ident: CR19
  article-title: The effects of silver nanoparticles and doxorubicin combination on DNA structure and its antiproliferative effect against T47D and MCF7 cell lines
  publication-title: J Biomed Nanotechnol
  doi: 10.1166/jbn.2012.1451
– year: 2014
  ident: CR16
  publication-title: Apoptosis and molecular targeting therapy in cancer
  doi: 10.1155/2014/150845
– volume: 149
  start-page: 110380
  year: 2022
  ident: CR61
  article-title: Gabapentin-loaded silver nanoparticles (GBP@ AgNPs) for their promising biomedical application as a nano-drug: anticancer and antimicrobial activities
  publication-title: Inorg Chem Commun
  doi: 10.1016/j.inoche.2022.110380
– volume: 76
  start-page: 1479
  issue: 14
  year: 2010
  end-page: 1491
  ident: CR34
  article-title: Potential of Cameroonian plants and derived products against microbial infections: a review
  publication-title: Planta Med
  doi: 10.1055/s-0030-1250027
– volume: 4
  start-page: 100205
  year: 2021
  ident: CR59
  article-title: Conventional and green methods of synthesis of silver nanoparticles and their antimicrobial properties
  publication-title: Current Res Green Sustainable Chem
  doi: 10.1016/j.crgsc.2021.100205
– volume: 22
  start-page: 105
  issue: 3
  year: 2018
  ident: CR14
  article-title: C6 cell line: The gold standard in glioma research
  publication-title: Hippokratia
– volume: 10
  start-page: 8996
  issue: 20
  year: 2020
  ident: CR60
  article-title: Silver nanoparticles: synthesis, medical applications, and biosafety
  publication-title: Theranostics
  doi: 10.7150/thno.45413
– volume: 73
  start-page: 3
  year: 2011
  end-page: 16
  ident: CR23
  article-title: Montmorillonite-alginate nanocomposite beads as a drug carrier for oral administration of carboplatin-preparation and characterization
  publication-title: UPB Sci Bull Series b
– volume: 97
  start-page: 115
  year: 2017
  end-page: 122
  ident: CR29
  article-title: Characterization and carboplatin-loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies
  publication-title: Int J Biol Macromol
  doi: 10.1016/j.ijbiomac.2016.12.090
– ident: CR58
– volume: 7
  start-page: 771
  issue: 9
  year: 2008
  end-page: 782
  ident: CR10
  article-title: Nanoparticle therapeutics: an emerging treatment modality for cancer
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2614
– volume: 8
  start-page: 14368
  issue: 1
  year: 2018
  ident: CR49
  article-title: Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-32480-5
– volume: 16
  start-page: 1
  issue: 1
  year: 2015
  end-page: 27
  ident: CR41
  article-title: Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report
  publication-title: Biomacromol
  doi: 10.1021/bm501285t
– volume: 9
  start-page: 1555
  year: 2018
  ident: CR38
  article-title: In vitro antimicrobial activity of green synthesized silver nanoparticles against selected gram-negative foodborne pathogens
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2018.01555
– volume: 10
  start-page: 913
  issue: 4
  year: 2018
  ident: CR55
  article-title: Plant-extract-assisted green synthesis of silver nanoparticles using L. extract and their microbicidal activities
  publication-title: Sustainability
  doi: 10.3390/su10040913
– volume: 8
  start-page: 2
  issue: 1
  year: 2018
  end-page: 11
  ident: CR12
  article-title: Antimicrobial nanoparticles: applications and mechanisms of action
  publication-title: SLJID
  doi: 10.4038/sljid.v8i1.8167
– volume: 13
  start-page: 416
  issue: 1
  year: 2020
  end-page: 425
  ident: CR45
  article-title: Synthesis and characterization of ciprofloxacin-loaded silver nanoparticles and investigation of their antibacterial effect
  publication-title: J Radiat Res Appl Sci
  doi: 10.1080/16878507.2020.1748941
– volume: 14
  start-page: 1469
  year: 2019
  ident: CR37
  article-title: Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S191340
– volume: 35
  start-page: 4799
  year: 2014
  end-page: 4806
  ident: CR11
  article-title: Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
  publication-title: Tumor Biology
  doi: 10.1007/s13277-014-1630-9
– volume: 61
  start-page: 104600
  year: 2019
  ident: CR20
  article-title: Silver nanoparticle/capecitabine for breast cancer cell treatment
  publication-title: Toxicol in Vitro
  doi: 10.1016/j.tiv.2019.104600
– volume: 8
  start-page: 1400
  issue: 9
  year: 2020
  ident: CR57
  article-title: Antibacterial activity of silver and its application in dentistry, cardiology, and dermatology
  publication-title: Microorganisms
  doi: 10.3390/microorganisms8091400
– volume: 69
  start-page: 102
  year: 2018
  end-page: 109
  ident: CR48
  article-title: Antibacterial properties and compressive strength of new one-step preparation silver nanoparticles in glass ionomer cements (NanoAg-GIC)
  publication-title: J Dent
  doi: 10.1016/j.jdent.2017.12.003
– volume: 11
  start-page: 1999
  year: 2021
  ident: CR5
  article-title: Green synthesis of silver nanoparticles using diospyros malabarica fruit extract and assessments of their antimicrobial, anticancer and catalytic reduction of 4-nitrophenol (4-NP)
  publication-title: Nanomaterials
  doi: 10.3390/nano11081999
– volume: 61
  start-page: 1138
  issue: 9
  year: 2015
  end-page: 1155
  ident: CR18
  article-title: Current state of circulating microRNAs as cancer biomarkers
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2015.241190
– volume: 9
  start-page: 2673
  issue: 5
  year: 2019
  end-page: 2702
  ident: CR51
  article-title: Green synthesis of silver nanoparticles: biomolecule-nanoparticle organizations targeting antimicrobial activity
  publication-title: RSC Adv
  doi: 10.1039/C8RA08982E
– volume: 581
  start-page: 119283
  year: 2020
  ident: CR2
  article-title: Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2020.119283
– year: 2022
  ident: CR25
  article-title: Inhibition of Staphylococcus aureus α-hemolysin production using nanocurcumin capped Au@ ZnO nanocomposite
  publication-title: Bioinorg Chem Appl
  doi: 10.1155/2022/2663812
– volume: 2
  start-page: 46
  issue: 1
  year: 2022
  end-page: 51
  ident: CR32
  article-title: Effects of plant extract on prostate cancer cell culture
  publication-title: Ant J Bot
  doi: 10.30616/ajb.391985
– volume: 12
  start-page: 16165
  issue: 1
  year: 2022
  ident: CR40
  article-title: Biosynthesis of copper oxide nanoparticles mediated Annona muricata as cytotoxic and apoptosis inducer factor in breast cancer cell lines
  publication-title: Scient Reports
  doi: 10.1038/s41598-022-20360-y
– volume: 14
  start-page: 509
  issue: 6
  year: 2021
  ident: CR22
  article-title: Pt (II)-thiocarbohydrazone complex as cytotoxic agent and apoptosis inducer in Caov-3 and HT-29 Cells through the P53 and caspase-8 pathways
  publication-title: Pharmaceuticals
  doi: 10.3390/ph14060509
– ident: CR30
– year: 2022
  ident: CR52
  article-title: Involvement of gold and silver nanoparticles in lung cancer nanomedicines: A review
  publication-title: Mater Today
  doi: 10.1016/j.matpr.2022.04.199
– volume: 210
  start-page: 112254
  year: 2022
  ident: CR42
  article-title: Exploring silver nanoparticles for cancer therapy and diagnosis
  publication-title: Colloids Surf B
  doi: 10.1016/j.colsurfb.2021.112254
– ident: CR6
– volume: 61
  start-page: 102265
  year: 2021
  ident: CR9
  article-title: Selective cytotoxicity of paclitaxel bonded silver nanoparticle on different cancer cells
  publication-title: J Drug Deliv Sci Technol
  doi: 10.1016/j.jddst.2020.102265
– volume: 31
  start-page: 3649
  year: 2021
  end-page: 3656
  ident: CR4
  article-title: Magnetic field-assisted laser ablation of titanium dioxide nanoparticles in water for anti-bacterial applications
  publication-title: J J Inorg Organomet Polym
  doi: 10.1007/s10904-021-01973-8
– volume: 23
  start-page: 100884
  year: 2020
  ident: CR27
  article-title: Synergistic and enhanced anticancer effect of a facile surface modified non-cytotoxic silver nanoparticle conjugated with gemcitabine in metastatic breast cancer cells
  publication-title: Mater Today Commun
  doi: 10.1016/j.mtcomm.2019.100884
– volume: 5
  start-page: 190ra81
  issue: 190
  year: 2013
  ident: CR47
  article-title: Silver enhances antibiotic activity against gram-negative bacteria
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3006276
– volume: 241
  start-page: 52
  year: 2017
  end-page: 57
  ident: CR21
  article-title: Cytotoxicity and antiviral activity of electrochemical–synthesized silver nanoparticles against poliovirus
  publication-title: J Virol Methods
  doi: 10.1016/j.jviromet.2016.12.015
– volume: 26
  start-page: 3067
  issue: 11
  year: 2021
  ident: CR26
  article-title: Polyethylene glycol functionalized graphene oxide nanoparticles loaded with nigella sativa extract: a smart antibacterial therapeutic drug delivery system
  publication-title: Molecules
  doi: 10.3390/molecules26113067
– volume: 176
  start-page: 62
  year: 2019
  end-page: 69
  ident: CR28
  article-title: Synergetic effect of vancomycin-loaded silver nanoparticles for enhanced antibacterial activity
  publication-title: Colloids Surf B
  doi: 10.1016/j.colsurfb.2018.12.043
– volume: 1
  start-page: 1
  year: 2019
  end-page: 9
  ident: CR43
  article-title: Optimization on thermal treatment synthesis of lactoferrin nanoparticles via Taguchi design method
  publication-title: SN Appl Sci
  doi: 10.1007/s42452-019-1353-z
– ident: CR44
– volume: 12
  start-page: 821
  issue: 9
  year: 2020
  ident: CR33
  article-title: Silver nanomaterials for wound dressing applications
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics12090821
– volume: 13
  start-page: 1000
  issue: 7
  year: 2021
  ident: CR8
  article-title: Antitumor activity against human colorectal adenocarcinoma of silver nanoparticles: influence of [ag]/[pvp] ratio
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics13071000
– volume: 5
  start-page: 753
  year: 2010
  end-page: 762
  ident: CR56
  article-title: Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S11727
– volume: 194
  start-page: 560
  year: 2020
  end-page: 569
  ident: CR1
  article-title: Biosynthesis, characterization, and evaluation of the cytotoxic effects of biologically synthesized silver nanoparticles from root extracts on breast cancer cell line MCF-7
  publication-title: Biol Trace Elem Res
  doi: 10.1007/s12011-019-01791-7
– volume: 11
  start-page: 964
  issue: 4
  year: 2021
  ident: CR15
  article-title: Silver nanoparticles as carriers of anticancer drugs for efficient target treatment of cancer cells
  publication-title: Nanomaterials
  doi: 10.3390/nano11040964
– ident: CR31
– volume: 60
  year: 2020
  ident: CR17
  article-title: Targeted nano-drug delivery system for glioblastoma therapy: in vitro and in vivo study
  publication-title: J Drug Deliv Sci Technol
  doi: 10.1016/j.jddst.2020.102039
– volume: 52
  start-page: 4384
  issue: 16
  year: 2013
  end-page: 4388
  ident: CR35
  article-title: On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles
  publication-title: Angew Chem Int Ed
  doi: 10.1002/anie.201207721
– volume: 11
  start-page: 371
  issue: 6
  year: 2013
  end-page: 384
  ident: CR36
  article-title: Antimicrobial activity of metals: mechanisms, molecular targets, and applications
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro3028
– ident: CR7
– volume: 6
  start-page: 1
  issue: 1
  year: 2011
  end-page: 8
  ident: CR39
  article-title: Cytotoxic and apoptotic effects of six herbal plants against the human hepatocarcinoma (HepG2) cell line
  publication-title: Chinese Med
  doi: 10.1186/1749-8546-6-39
– volume: 13
  start-page: 1
  year: 2013
  end-page: 9
  ident: CR3
  article-title: Antimicrobial activity and cytotoxicity of the ethanol extract, fractions, and eight compounds isolated from (Fabaceae)
  publication-title: BMC Complement Altern Med
  doi: 10.1186/1472-6882-13-289
– volume: 63
  start-page: 14308
  issue: 23
  year: 2020
  end-page: 14335
  ident: CR46
  article-title: Cytotoxic effect of silver nanoparticles synthesized by green methods in cancer
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.0c01055
– volume: 85
  start-page: e729
  issue: 1017
  year: 2012
  end-page: e733
  ident: CR50
  article-title: A clinical review of treatment outcomes in glioblastoma multiforme the validation in a non-trial population of the results of a randomized Phase III clinical trial: has a more radical approach improved survival?
  publication-title: Brit J Radiol
  doi: 10.1259/bjr/83796755
– volume: 14
  start-page: 2183
  issue: 10
  year: 2022
  ident: CR13
  article-title: Impact of PEGylated liposomal doxorubicin and carboplatin combination on glioblastoma
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics14102183
– ident: CR24
– volume: 11
  start-page: 457
  issue: 4
  year: 2021
  end-page: 467
  ident: CR53
  article-title: Evaluation of anticancer and anti-bacterial effects of silver nanoparticles synthesized by L. extract on cancer cells MCF-7, HeLa and A549
  publication-title: J Chem Health Risks
  doi: 10.22034/JCHR.2021.1937062.1373
– volume: 12
  start-page: 16165
  issue: 1
  year: 2022
  ident: 243_CR40
  publication-title: Scient Reports
  doi: 10.1038/s41598-022-20360-y
– volume: 4
  start-page: 100205
  year: 2021
  ident: 243_CR59
  publication-title: Current Res Green Sustainable Chem
  doi: 10.1016/j.crgsc.2021.100205
– volume: 13
  start-page: 1000
  issue: 7
  year: 2021
  ident: 243_CR8
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics13071000
– volume: 12
  start-page: 148
  issue: 6
  year: 2009
  ident: 243_CR54
  publication-title: Drug Resist Updat
  doi: 10.1016/j.drup.2009.09.001
– ident: 243_CR44
  doi: 10.1088/1757-899X/757/1/012028
– volume: 6
  start-page: 1
  issue: 1
  year: 2011
  ident: 243_CR39
  publication-title: Chinese Med
  doi: 10.1186/1749-8546-6-39
– volume: 2
  start-page: 46
  issue: 1
  year: 2022
  ident: 243_CR32
  publication-title: Ant J Bot
  doi: 10.30616/ajb.391985
– volume: 210
  start-page: 112254
  year: 2022
  ident: 243_CR42
  publication-title: Colloids Surf B
  doi: 10.1016/j.colsurfb.2021.112254
– volume: 14
  start-page: 1469
  year: 2019
  ident: 243_CR37
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S191340
– volume: 13
  start-page: 416
  issue: 1
  year: 2020
  ident: 243_CR45
  publication-title: J Radiat Res Appl Sci
  doi: 10.1080/16878507.2020.1748941
– volume: 9
  start-page: 1555
  year: 2018
  ident: 243_CR38
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2018.01555
– volume: 35
  start-page: 4799
  year: 2014
  ident: 243_CR11
  publication-title: Tumor Biology
  doi: 10.1007/s13277-014-1630-9
– volume: 5
  start-page: 753
  year: 2010
  ident: 243_CR56
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S11727
– volume: 8
  start-page: 14368
  issue: 1
  year: 2018
  ident: 243_CR49
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-32480-5
– volume: 14
  start-page: 509
  issue: 6
  year: 2021
  ident: 243_CR22
  publication-title: Pharmaceuticals
  doi: 10.3390/ph14060509
– volume: 16
  start-page: 1
  issue: 1
  year: 2015
  ident: 243_CR41
  publication-title: Biomacromol
  doi: 10.1021/bm501285t
– volume: 11
  start-page: 964
  issue: 4
  year: 2021
  ident: 243_CR15
  publication-title: Nanomaterials
  doi: 10.3390/nano11040964
– volume: 11
  start-page: 371
  issue: 6
  year: 2013
  ident: 243_CR36
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro3028
– volume: 194
  start-page: 560
  year: 2020
  ident: 243_CR1
  publication-title: Biol Trace Elem Res
  doi: 10.1007/s12011-019-01791-7
– volume: 581
  start-page: 119283
  year: 2020
  ident: 243_CR2
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2020.119283
– volume: 61
  start-page: 102265
  year: 2021
  ident: 243_CR9
  publication-title: J Drug Deliv Sci Technol
  doi: 10.1016/j.jddst.2020.102265
– volume: 12
  start-page: 821
  issue: 9
  year: 2020
  ident: 243_CR33
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics12090821
– volume: 73
  start-page: 3
  year: 2011
  ident: 243_CR23
  publication-title: UPB Sci Bull Series b
– volume: 61
  start-page: 1138
  issue: 9
  year: 2015
  ident: 243_CR18
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2015.241190
– volume: 23
  start-page: 100884
  year: 2020
  ident: 243_CR27
  publication-title: Mater Today Commun
  doi: 10.1016/j.mtcomm.2019.100884
– volume: 241
  start-page: 52
  year: 2017
  ident: 243_CR21
  publication-title: J Virol Methods
  doi: 10.1016/j.jviromet.2016.12.015
– volume: 14
  start-page: 2183
  issue: 10
  year: 2022
  ident: 243_CR13
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics14102183
– volume: 60
  year: 2020
  ident: 243_CR17
  publication-title: J Drug Deliv Sci Technol
  doi: 10.1016/j.jddst.2020.102039
– ident: 243_CR58
  doi: 10.1155/2020/1215395
– volume: 176
  start-page: 62
  year: 2019
  ident: 243_CR28
  publication-title: Colloids Surf B
  doi: 10.1016/j.colsurfb.2018.12.043
– volume: 11
  start-page: 1999
  year: 2021
  ident: 243_CR5
  publication-title: Nanomaterials
  doi: 10.3390/nano11081999
– volume: 10
  start-page: 8996
  issue: 20
  year: 2020
  ident: 243_CR60
  publication-title: Theranostics
  doi: 10.7150/thno.45413
– volume: 8
  start-page: 2
  issue: 1
  year: 2018
  ident: 243_CR12
  publication-title: SLJID
  doi: 10.4038/sljid.v8i1.8167
– year: 2022
  ident: 243_CR52
  publication-title: Mater Today
  doi: 10.1016/j.matpr.2022.04.199
– ident: 243_CR24
  doi: 10.1088/1757-899X/454/1/012077
– ident: 243_CR30
  doi: 10.1088/1742-6596/1003/1/012100
– volume: 10
  start-page: 913
  issue: 4
  year: 2018
  ident: 243_CR55
  publication-title: Sustainability
  doi: 10.3390/su10040913
– volume: 11
  start-page: 457
  issue: 4
  year: 2021
  ident: 243_CR53
  publication-title: J Chem Health Risks
  doi: 10.22034/JCHR.2021.1937062.1373
– volume: 63
  start-page: 14308
  issue: 23
  year: 2020
  ident: 243_CR46
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.0c01055
– volume-title: Apoptosis and molecular targeting therapy in cancer
  year: 2014
  ident: 243_CR16
  doi: 10.1155/2014/150845
– volume: 97
  start-page: 115
  year: 2017
  ident: 243_CR29
  publication-title: Int J Biol Macromol
  doi: 10.1016/j.ijbiomac.2016.12.090
– volume: 149
  start-page: 110380
  year: 2022
  ident: 243_CR61
  publication-title: Inorg Chem Commun
  doi: 10.1016/j.inoche.2022.110380
– volume: 13
  start-page: 1
  year: 2013
  ident: 243_CR3
  publication-title: BMC Complement Altern Med
  doi: 10.1186/1472-6882-13-289
– ident: 243_CR31
  doi: 10.3390/pharmaceutics14102185
– volume: 69
  start-page: 102
  year: 2018
  ident: 243_CR48
  publication-title: J Dent
  doi: 10.1016/j.jdent.2017.12.003
– year: 2022
  ident: 243_CR25
  publication-title: Bioinorg Chem Appl
  doi: 10.1155/2022/2663812
– volume: 8
  start-page: 968
  issue: 6
  year: 2012
  ident: 243_CR19
  publication-title: J Biomed Nanotechnol
  doi: 10.1166/jbn.2012.1451
– volume: 22
  start-page: 105
  issue: 3
  year: 2018
  ident: 243_CR14
  publication-title: Hippokratia
– volume: 76
  start-page: 1479
  issue: 14
  year: 2010
  ident: 243_CR34
  publication-title: Planta Med
  doi: 10.1055/s-0030-1250027
– volume: 31
  start-page: 3649
  year: 2021
  ident: 243_CR4
  publication-title: J J Inorg Organomet Polym
  doi: 10.1007/s10904-021-01973-8
– volume: 8
  start-page: 1400
  issue: 9
  year: 2020
  ident: 243_CR57
  publication-title: Microorganisms
  doi: 10.3390/microorganisms8091400
– ident: 243_CR6
– volume: 1
  start-page: 1
  year: 2019
  ident: 243_CR43
  publication-title: SN Appl Sci
  doi: 10.1007/s42452-019-1353-z
– volume: 61
  start-page: 104600
  year: 2019
  ident: 243_CR20
  publication-title: Toxicol in Vitro
  doi: 10.1016/j.tiv.2019.104600
– volume: 85
  start-page: e729
  issue: 1017
  year: 2012
  ident: 243_CR50
  publication-title: Brit J Radiol
  doi: 10.1259/bjr/83796755
– volume: 7
  start-page: 771
  issue: 9
  year: 2008
  ident: 243_CR10
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2614
– volume: 26
  start-page: 3067
  issue: 11
  year: 2021
  ident: 243_CR26
  publication-title: Molecules
  doi: 10.3390/molecules26113067
– volume: 9
  start-page: 2673
  issue: 5
  year: 2019
  ident: 243_CR51
  publication-title: RSC Adv
  doi: 10.1039/C8RA08982E
– ident: 243_CR7
– volume: 5
  start-page: 190ra81
  issue: 190
  year: 2013
  ident: 243_CR47
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3006276
– volume: 52
  start-page: 4384
  issue: 16
  year: 2013
  ident: 243_CR35
  publication-title: Angew Chem Int Ed
  doi: 10.1002/anie.201207721
SSID ssj0000399909
Score 2.4829626
Snippet In recent studies with silver nanoparticles, it has been reported that the use of nanoparticles in carrier drug systems increases tumor suppression and reduces...
Abstract In recent studies with silver nanoparticles, it has been reported that the use of nanoparticles in carrier drug systems increases tumor suppression...
SourceID doaj
unpaywall
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 2
SubjectTerms AgNPs
Anticancer properties
Antimicrobial
Antimicrobial agents
Apoptosis
Biochemistry
Biomedical Engineering and Bioengineering
Cancer
Cancer Research
Carboplatin
Chemistry and Materials Science
Drug carrier
Drug carriers
Glioma
Lung cancer
Materials Science
Microorganisms
Nanomaterials
Nanoparticles
Nanotechnology
Side effects
Silver
Traditional medicine
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqHigcKiggti3IB27UavyIEx8LoqqQ4EIr9Wb5Ka20OKvNVmgv_PaOnWy6vRQOHJP4PWPPTDzzDUIfaWSBOlaTaE1NhHGeGBc58aLhcCYHMHOLg-wPeXUjvt3WtzupvrJP2AAPPCzcuZWi9jlPEmwHIaO0wkfZBmkYi431JY68atWOMVXOYJC7qvh3ZDh4IlXdbiNmWnneU1ADcmAyJwWRj9BHUqmA9z_SOKdL0hfo4C4tzea3WSx25NDlS3Q4KpD4Yhj4K7QX0hF69n28In-N_vzcJFDq-nmPTfLYTYDMQ7wl7iLu59kdGieTwGIeHePwojM-eJz_y2JnVrZbZi-5hA20g5fdOnsVQb9AiPmveUFvKk_QQ-abFR4CuTZv0M3l1-svV2RMskAciKI1CVUdG0UN98byLNxZzYyVOXyHB1kJI1kIDZwDyqkGKG4do0EY4TiLrbKSv0X7qUvhHcLKBSEqyxornQjUtsIwGyqvuGCsYWGG6HaRtRsRyHMijIUulkgr9UAYDYTRhTCaztCnqc5ywN94svTnTLupZMbOLi-Ao_S4oPpvHDVDp1vK63FD95qBWtWwFqrO0NmWGx4-PzWks4lj_mEGx_9jBifoOYPmBq-bU7S_Xt2F96A7re2Hsk3uAVPlEZQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9QwFLZQK7EcKlZ1oCAfuFGL5Nmxk2OLqCokuMBIvVle0UhDMppMhebCb-fZWWglVMEti5fE7_kt9nufCXlbRgilg4pFayomjPPMuMiZF4qjTA7o5uYA2S_ycik-XVVXY1JYP0W7T1uSWVLnaV3L932JujtlE3OWYfQY-jyHVYLzQi5ewtm8slKgzm1ybEeCgmeyqeopW-avzdzSSBm4_5a1OW-QPiIPrtuN2f806_UNHXTxmByNxiM9G6j9hNwL7VNy__O4Pf6M_Pq6b9Gg61c9Na2nbgZjHnItaRdpv0qh0LQ1LXrLY1AcXXfGB0_Tmix1Zmu7TYqQa6nBduim26WIIuwXibD6scrITfkOe0g8s6VDEtf-OVlefPz24ZKNBywwh2pox0JRRdWUhntjeVLsUIGxMqXu8CALYSSEoFAGNK5RSG3roAzCCMch1o2V_AU5aLs2HBPauCBEYUFZ6UQobS0M2FD4hgsABWFBymmQtRvRx9MhGGudvZBa6oEwGgmjM2F0uSDv5jqbAXvjztLniXZzyYSbnR902-96HFBtsZJPp26hcBUySit8lHWQBiAq69WCnEyU1-Nk7jWgSaWgxqoLcjpxw5_Xd33S6cwx__AHL_-v9VfkIeDVEFtzQg522-vwGi2knX2TJ8RvfsMGGw
  priority: 102
  providerName: Springer Nature
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQVuJxoDzFloJ84Ea93TiOkxxLRVUhUSHBSuVk-YlWTZMoyQotB357x86DFqEKJG5OYseeyXg8juebQehN5KiNNE2IUzIhTGpDpHYxMSyNQSdb2OYGB9kzfrpiH86T8wEe3QbANtDakFKW1eI6AL3o8Q0-f4JtDmvj-ume8cM2gjXdo4xjEsLrEdgL7fAELPMZ2lmdfTr66vdcGc8Iz0O6zqHM-Yih-eNLbqxTIZz_DRt0OjZ9gO5tylpuv8uiuLYyneyiy5Gm3iHlYrHp1EL_-C3c4_8i-hF6OJiw-KiXucfoji2foLsfh0P6p-jn520JZmW7brEsDdZTSOge8Ykrh9u1d8jGfij16JqHi0oaa7D_M4y1bFRVez-9Ekt4D66rzvs1Qb8gCuvLdYgfFa6gh0AY7qFk22dodfL-y_EpGdI8EA2LYUfsMnFpHsnYSBV784ImVCruAUSx5UsmObU2BU2U6zwFmVOaRpZJpmPqslzx-DmalVVpXyCca8vYUtFUcc1spDImqbJLk8eM0pTaOYrGjyr0EAPdp-IoRNgLZVz0jBXAWBEYK6I5eju1qfsIILfWfudlZarpo3eHG1XzTQwMFQoaGZ_7C1Q8444rZhzPLJeUulSZdI72R0kTg0ppBQXDLqUZNJ2jg1H6fj2-bUgHk4T-BQV7_1b9JbpPodR7-OyjWdds7Cuw0zr1eph-V1tHNEc
  priority: 102
  providerName: Unpaywall
Title Synthesis and characterization of silver nanoparticles loaded with carboplatin as a potential antimicrobial and cancer therapy
URI https://link.springer.com/article/10.1186/s12645-023-00243-1
https://www.proquest.com/docview/2910728645
https://cancer-nano.biomedcentral.com/counter/pdf/10.1186/s12645-023-00243-1
https://doaj.org/article/b645d602608846f6b4df68e6a22f7bd7
UnpaywallVersion publishedVersion
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Openly Available Collection - DOAJ
  customDbUrl:
  eissn: 1868-6966
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399909
  issn: 1868-6958
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: ProQuest Technology Collection
  customDbUrl:
  eissn: 1868-6966
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399909
  issn: 1868-6958
  databaseCode: 8FG
  dateStart: 20101201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/technologycollection1
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature HAS Fully OA
  customDbUrl:
  eissn: 1868-6966
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399909
  issn: 1868-6958
  databaseCode: AAJSJ
  dateStart: 20101201
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1868-6966
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399909
  issn: 1868-6958
  databaseCode: C24
  dateStart: 20100112
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 1868-6966
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399909
  issn: 1868-6958
  databaseCode: C6C
  dateStart: 20100112
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1868-6966
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000399909
  issn: 1868-6958
  databaseCode: U2A
  dateStart: 20101201
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Li9swEB52E-jjUPqkabdBh966YmNZluxDKdmw6RJoWLoNbE9GL5dAaqdJlpJLf3tH8mO7l9CLwLZk2ZrRzEia-QbgfVQwFxmW0EKrhHJlLFWmiKnlMkaZ7HCZGxxk5-JywWc3yc0RzNtYGO9W2crEIKhtZfwe-RlDvSZZKnjyaf2L-qxR_nS1TaGhmtQK9mOAGDuGPvPIWD3on1_Mr752uy4j1MdZ8PvwMPFUZEnaRtKk4mwboXngA5ZjGpD6aHRPWwVQ_3uWaHd4-hge3pZrtf-tVqt_9NP0KTxpDEsyrjnhGRy58jk8-NIcnb-AP9f7Eo297XJLVGmJ6YCa6zhMUhVku_Ru0qRUJa6kG4c5sqqUdZb4_Vpi1EZXa-89VxKF7yHraue9jbBfJNDy5zKgOoUr7MHz04bUAV77l7CYXnybXNIm-QI1qKJ21I2SQmaRiq3SsVf6LGFKCx_WEzsx4kow5yTKh8xkEjlBGxY5rriJWZFmWsSvoFdWpXsNJDOO85FmUgvDXaRTrph2I5vFnDHJ3ACidpBz0yCT-wQZqzysUFKR14TJkTB5IEweDeBD12Zd43IcrH3uadfV9Jja4Ua1-ZE3A5prbGR9Ri4UvFwUQnNbiNQJxVghtZUDOGkpnzcTfZvfseUATltuuHt86JNOO475jz94c7jzt_CIYcXaz-YEervNrXuH1tJOD-FY3kgs0-nnIfTH49n1bNhMC7w7YdyXYjIMuxFYLhiW_cX8avz9L6W9GFE
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw1CqtROGAWMVAAR_gRK0mtuMkhwpRaDWl7QhBK_XmegsaaUjCZKpqLnwa38azs5ReRlx6TOIl9tvttyD0Ni6oiw1NSKFVQrgylihTMGJ5yoAnOzBzg4PsRIzP-Jfz5HwN_eljYbxbZc8TA6O2lfFn5DsU5FpKM8GTD_Uv4qtG-dvVvoSG6kor2N2QYqwL7Dhyyysw4Zrdw88A73eUHuyffhqTrsoAMcCLF8RFSZHmsWJWaealG02o0sLHrzAnIq4EdS4FQshNnsKStaGx44obRoss14LBuHfQBmc8B-NvY29_8vXbcMoTgfzPg5-JT0tPRJ5kfeROJnaaGNQRHyDNSMgMSOIb0jEUEbih-Q6XtffR5mVZq-WVms3-kYcHD9GDTpHFH1vMe4TWXPkY3T3pruqfoN_flyUol820waq02AyJodu4T1wVuJl6t2xcqhIs985BD88qZZ3F_nwYGzXXVe299UqsYBxcVwvv3QTzAkJMf05DFqnwBDN4_J3jNqBs-RSd3QoYnqH1sirdc4Rz4ziPNE21MNzFOuOKahfZnHFKU-pGKO43WZouE7ovyDGTwSLKhGwBIwEwMgBGxiP0fuhTt3lAVrbe87AbWvoc3uFFNf8huw2VGjpZXwEMGD0XhdDcFiJzQlFapNqmI7TVQ152jKWR12QwQts9Nlx_XvVL2wPG_McKXqye_A3aHJ-eHMvjw8nRS3SPQqfWx2cLrS_ml-4VaGoL_bojB4wubpsC_wKbBEwD
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKkQocEKsYKOADnKg1ie3YyQEhoIxaChUSVJqb8RY00jSZTqaq5sIP49fx7CyllxGXHrPYTvxW2997D6FXaUl9amlGSqMzwrV1RNuSEcclA53sYZkbAbLH4uCEf55m0y30p4-FCbDKXidGRe1qG_bIxxTsmqS54Nm47GAR3_Yn7xZnJFSQCietfTmNlkWO_PoClm_N28N9oPVrSieffnw8IF2FAWJBD6-IT7JSFqlmThsWLBvNqDYixK4wLxKuBfVeghAUtpDwu8bS1HPNLaNlXhjBoN8b6KZkrAhwQjmVw_5OApa_iAiTkJCeiCLL-5idXIybFByREBrNSMwJSNIrdjGWD7ji8w7HtHfQrfNqodcXej7_xxJO7qG7nQuL37c8dx9t-eoB2vnaHdI_RL-_rytwK5tZg3XlsB1SQrcRn7gucTMLgGxc6QrW7B00D89r7bzDYWcYW7009SLg9CqsoR-8qFcB1wTjAivMTmcxf1S8ghEC5y5xG0q2foROroUIj9F2VVf-CcKF9ZwnhkojLPepybmmxieuYJxSSf0Ipf0kK9vlQA-lOOYqroVyoVrCKCCMioRR6Qi9Gdos2gwgG9_-EGg3vBmyd8cb9fKX6iZUGWjkQu0vUPFclMJwV4rcC01pKY2TI7TbU151KqVRlwIwQns9N1w-3vRJewPH_McfPN08-Eu0A3KnvhweHz1Dtym0acE9u2h7tTz3z8FFW5kXURYw-nndwvcXa05JnQ
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQVuJxoDzFloJ84Ea93TiOkxxLRVUhUSHBSuVk-YlWTZMoyQotB357x86DFqEKJG5OYseeyXg8juebQehN5KiNNE2IUzIhTGpDpHYxMSyNQSdb2OYGB9kzfrpiH86T8wEe3QbANtDakFKW1eI6AL3o8Q0-f4JtDmvj-ume8cM2gjXdo4xjEsLrEdgL7fAELPMZ2lmdfTr66vdcGc8Iz0O6zqHM-Yih-eNLbqxTIZz_DRt0OjZ9gO5tylpuv8uiuLYyneyiy5Gm3iHlYrHp1EL_-C3c4_8i-hF6OJiw-KiXucfoji2foLsfh0P6p-jn520JZmW7brEsDdZTSOge8Ykrh9u1d8jGfij16JqHi0oaa7D_M4y1bFRVez-9Ekt4D66rzvs1Qb8gCuvLdYgfFa6gh0AY7qFk22dodfL-y_EpGdI8EA2LYUfsMnFpHsnYSBV784ImVCruAUSx5UsmObU2BU2U6zwFmVOaRpZJpmPqslzx-DmalVVpXyCca8vYUtFUcc1spDImqbJLk8eM0pTaOYrGjyr0EAPdp-IoRNgLZVz0jBXAWBEYK6I5eju1qfsIILfWfudlZarpo3eHG1XzTQwMFQoaGZ_7C1Q8444rZhzPLJeUulSZdI72R0kTg0ppBQXDLqUZNJ2jg1H6fj2-bUgHk4T-BQV7_1b9JbpPodR7-OyjWdds7Cuw0zr1eph-V1tHNEc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+characterization+of+silver+nanoparticles+loaded+with+carboplatin+as+a+potential+antimicrobial+and+cancer+therapy&rft.jtitle=Cancer+nanotechnology&rft.au=Tun%C3%A7%2C+Tutku&rft.date=2024-12-01&rft.pub=Springer+Nature+B.V&rft.issn=1868-6958&rft.eissn=1868-6966&rft.volume=15&rft.issue=1&rft.spage=2&rft_id=info:doi/10.1186%2Fs12645-023-00243-1&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1868-6958&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1868-6958&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1868-6958&client=summon